NovoMix 30

insulin aspart protamine fixed-dose combination · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

24 regulatory and trial events tracked for NovoMix 30, covering 2013-09-12 to 2018-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin [Phase 4]

See pricing